Match Document Document Title
US20130330404 Extended release composition containing tramadol  
An oral tramadol pharmaceutical composition for once daily administration, containing an effective amount of tramadol or a pharmaceutically-acceptable salt thereof, providing in vivo, a time of...
US20120052119 NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL  
Embodiments of the present invention are directed to articles of manufacture and methods of making such articles having utility for the delivery of cannabinoids as a therapeutic. One embodiment of...
US20140363490 OLIGOMER-CONTAINED NANOPARTICLE COMPLEX RELEASE SYSTEM  
An oligomer-contained nanoparticle complex is provided. The oligomer-contained nanoparticle complex of the invention comprises (a) a nanoparticle, (b) a polymer with high molecule weigh, (c) a...
US20080292690 MULTI-MEMBRANE IMMUNOISOLATION SYSTEM FOR CELLULAR TRANSPLANT  
This invention relates to an immunoisolation encapsulation system that protects cellular transplants and thus allows cell function and survival without the need of immunosuppression. The...
US20120294935 PROCESS FOR THE PRECIPITATION AND ISOLATION OF 6,6-DIMETHYL-3-AZA-BICYCLO [3.1.0] HEXANE-AMIDE COMPOUNDS BY CONTROLLED PRECIPITATION AND PHARMACEUTICAL FORMULATIONS CONTAINING SAME  
The present invention provides a method of continuous precipitation and isolation of an amorphous solid particulate form of...
US20070071808 Capsule filled with honey  
Capsules containing honey or other sweeteners that may be added to beverages are described. The capsules may be made from a material that dissolves in water or other fluids, or, alternatively, the...
US20050197321 Treatment of sepsis  
The present invention provides a treatment for sepsis comprising an intravenous solution or pill that contains creatine phosphate and is devoid of carbohydrates. The intravenous solution can be...
US20110305755 METHOD OF ADDING BOTANICAL AGENTS/DIETARY SUPPLEMENTS TO PHARMACEUTICAL AGENTS IN A PHARMACOTHERAPEUTIC REGIMEN  
A method for administering an active pharmaceutical agent (APA) is provided that includes the steps of: a) providing a medicine having a dose of at least one APA and at least one active botanical...
US20110293710 Immunomodulatory properties of lactobacillus strains  
A specific method is provided of improving immunomodulatory properties of Lactobacillus strains using growth media with a specific primary carbon source, including a method of increasing the...
US20130004565 PROTEOLYTIC ENZYME FORMULATIONS  
Preferred embodiments of the present invention relate to proteolytic enzyme formulations. More specifically, several embodiments relate to a proteolytic formulation to facilitate digestion,...
US20110014279 BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF  
A bioactive complex composition having enhanced oxidative stability, emulsion stability, mineral rich transparent beverages and a wide range of functional health benefits. The composition may...
US20100310648 PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR  
The invention relates to a pharmaceutical dosage form which comprises a solid dispersion product comprising...
US20130315991 GASTRO-RETENTIVE DRUG DELIVERY SYSTEM FOR CONTROLLED DRUG RELEASE IN THE STOMACH AND INTO THE UPPER INTESTINES  
A gastro-retentive drug delivery system for controlled release of drugs in the stomach or upper gastro-intestinal track provides one or more polymers that hydrate and swell to immobilize the drug...
US20110293696 COMPOSITIONS AND METHODS FOR TREATING BRUISES  
A composition for the treatment of bruising is disclosed. The composition can include an antioxidant, one or more citrus flavanoids, as active agents along with a pharmaceutically acceptable...
US20150174078 Sustained Release Formulations of Lorazepam  
A pharmaceutical composition for delivering lorazepam in a prolonged fashion is achieved with prolonged release lorazepam pharmaceutical beads. The composition typically contains sustained release...
US20120052120 NANOTECHNOLOGY FORMULATION OF POORLY SOLUBLE COMPOUNDS  
Embodiments of the present invention are directed to articles of manufacture, spheres having a diameter of 50 to 500 nanometers which contain poorly soluble drugs and methods of making such...
US20090035366 Nanoparticulate benzothiophene formulations  
The present invention is directed to benzothiophene compositions, preferably nanoparticulate raloxifene hydrochloride compositions having improved pharmacokinetic profiles, improved...
US20140248340 COATED CONTROLLED RELEASE ACTIVE AGENT CARRIERS  
The present invention relates to carriers for the controlled release of active agents, comprising a core, comprising surface reacted natural or synthetic calcium carbonate, and at least one active...
US20050220862 Compositions with reduced hepatotoxicity  
Pharmaceutical compositions of hepatotoxic compounds are provided in which the hepatotoxicity of the compounds is mitigated by including quantities of nicotinamide and methionine in the...
US20130287842 Hard Capsules  
Publicly available pullulan hard capsule shells present certain drawbacks, notably a non fully satisfactory shell mechanical strength (i.e. shell brittleness) at shell low LOD. Improving this...
US20080139654 ACETAMINOPHEN COMPOSITIONS HAVING MINIMIZED SIDE EFFECTS INCLUDING REDUCED HEPATOTOXICITY  
Solid tablets or gel capsules comprising acetaminophen and an agent that promotes glutathione production that mitigates adverse hepatic effects of acetaminophen. The glutathione production...
US20130101668 TRANSITION METAL MEDIATED OXIDATION OF HETERO ATOMS IN ORGANIC MOLECULES COORDINATED TO TRANSITION METALS: OXIDATION OF COORDINATED BENZIMIDAZOLE TO OMEPRAZOLE  
The present invention is directed to a process for the catalytic oxidation of the thioether 5-methoxy-2-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)meth ylthio)-1H-benzimidazole to its sulfoxide:...
US20110052679 SOLID NAPROXEN CONCENTRATES AND RELATED DOSAGE FORMS  
The invention provides a composition consisting essentially of a solid naproxen concentrate, wherein the solid naproxen concentrate comprises (a) a solid naproxen free acid and (b) a solid...
US20130302412 Transfer Factor Compositions  
Compositions containing therapeutically effective amounts of transfer factor and one or more compounds selected from glucosamine salts, dimethyl glycine, chondroitin, montmoril-lonite, curcumin,...
US20110033527 Opthalmic compositions of cyclosporin  
Lipid-polymer compounds are used to solubilize cyclosporin. Diacylglycerol-polyethyleneglycols (DAG-PEGs) are especially useful in this regard. A preferred embodiment of the invention is an...
US20120128766 Self-Breaking Tablets  
Self-breaking core tablets and functionally coated tablets and capsule formulations are provided. Methods for production of these tablet and capsule formulations and their administration are also...
US20150258121 COMPOSITIONS AND METHODS FOR FORMING STABILIZED COMPOSITIONS WITH REDUCED CSA AGGLOMERATION  
Compositions and methods for preparing stabilized CSA compositions having reduced agglomeration and increased stability. The compositions have increased efficacy in killing microbes and reduced...
US20070042035 Soft capsule  
It is an object of the present invention to provide a capsule anti-sticking agent which can provide excellent anti-sticking effect on a soft capsule without impairing various properties such as...
US20130224288 F, G, H, I and K Crystal Forms of Imatinib Mesylate  
The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of...
US20120015027 F, G, H, I and K Crystal Forms of Imatinib Mesylate  
The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of...
US20110171301 F, G, H, I and K Crystal Forms of Imatinib Mesylate  
The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of...
US20140017305 ENCAPSULATED LIVER CELL COMPOSITION  
Microcapsules including a capsule shell encapsulating a suspension of a therapeutically effective amount of liver cells in physical contact with a liver cell stimulating amount of erythropoietin.
US20150132372 AQUEOUS DISPERSIONS OF CONTROLLED RELEASE POLYMERS AND SHELLS AND CAPSULES THEREOF  
The present disclosure relates to aqueous compositions for use in the manufacture of capsule shells and capsules with a functional polymer dispersion. The present disclosure relates to aqueous...
US20050186267 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin  
A capsule containing an aqueous fill composition that comprises water, a derivatized cyclodextrin, such as sulfoalkyl ether cyclodextrin (SAE-CD) or hydroxypropyl cyclodextrin (HPCD), optionally...
US20140105972 PREVOTELLA HISTICOLA PREPARATIONS AND THE TREATMENT OF AUTOIMMUNE CONDITIONS  
This document provides methods and materials related to Prevotella histicola preparations. For example, Prevotella histicola preparations in the form of an oral medicament or dietary supplement...
US20070269473 Microbial Encapsulation  
The present invention relates to a method of encapsulation and a composition comprising an encapsulate material.
US20110081413 Pharmaceutical Compositions Comprising Phosphate-Binding Polymer  
The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion....
US20120231072 THERMO-RESPONSIVE HYDROGEL COMPOSITIONS  
A thermo-responsive hydrogel, including a biocompatible monomer and/or polymer having an amino acid side chain. The hydrogel is thermo-responsive at a physiological temperature, and can include,...
US20070026062 Tablet comprising a fibrate  
Stable tablets and pharmaceutical compositions in particulate form comprising a fibrate, for example fenofibrate, dissolved or dispersed in an non-aqueous vehicle with improved bioavailability,...
US20050143410 Novel crystalline anhydrate with anticholinergic efficacy  
The invention relates to a new crystalline anhydrate of tiotropium bromide, processes for preparing it and its use for preparing a pharmaceutical composition for the treatment of respiratory...
US20130157863 MICROCAPSULE DISPERSION COMPRISING MICROCAPSULES WITH A HYDROPHILIC CAPSULE CORE  
The present invention relates to microcapsule dispersions comprising microcapsules comprising a hydrophilic capsule core and a capsule wall polymer which is obtainable by polymerization of a...
US20060257469 Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase  
It is the embodiment of this invention to form novel compositions of Indoleamines e.g. 5-Hydroxytryptophan (5HTP) and/or Catecholamines e.g. L-Dopa with the gallocatechins e.g....
US20140017307 LIQUID LAUNDRY DETERGENTS WITH PERFUME CAPSULES  
The present invention relates to a structured liquid composition comprising anionic surfactant, nonionic surfactant and a plurality of stable and evenly suspended encapsulated actives. The liquid...
US20110091539 Micronized Tanaproget and Compositions Containing Same  
The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose...
US20130280323 Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture  
Disclosed herein is a soft elastic capsule that includes an acid resistant, capsule shell that defines an encapsulated space having a predetermined volume, a liquid or semisolid fill comprising a...
US20080193491 Diaminooxidase-Containing Pharmaceutical Compositions  
The present invention relates to pharmaceutical compositions, food supplement compositions and cosmetic compositions comprising diaminooxidase, and to the use thereof.
US20130209555 Formulations and Dosage Forms of Oxidized Phospholipids  
The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4′-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening...
US20050158377 Dermatologic soft gel compositions  
Orally administrable softgels or soft gelatin capsules and fill compositions therefore for use in treating various dermatological conditions. These compositions are also particularly useful for...
US20130052261 PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME  
The present invention discloses a pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A...
US20120114747 PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHOD OF MAKING SAME  
The present invention discloses pharmaceutical-grade ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. A...